MedDataX Logo

Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients

NCT ID: NCT03172013

Last Updated: 2017-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-11

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection in cirrhotic patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Platelet indices can be utilized as a non-invasive predictor of SBP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cirrhosis, Liver

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cirrhotic ascitic patients with SBP,

Cirrhotic ascitic patients with SBP,

Platelet indices

Intervention Type DIAGNOSTIC_TEST

MPV, PDW

cirrhotic ascitic patients without SBP,

cirrhotic ascitic patients without SBP,

Platelet indices

Intervention Type DIAGNOSTIC_TEST

MPV, PDW

Healthy volunteers

Healthy individuals

Platelet indices

Intervention Type DIAGNOSTIC_TEST

MPV, PDW

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Platelet indices

MPV, PDW

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cirrhotic patients and ascites

Exclusion Criteria

* patients with ascites due to causes other than cirrhosis- immunocompromised patients,
* patients with abnormal thrombocytes due to non-hepatic causes.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Taher Eldemerdash, Professor

Role: PRINCIPAL_INVESTIGATOR

Consultant of Hepatology - Tanta University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tanta university hospital

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sherief Abd-Elsalam, consultant

Role: CONTACT

Phone: 00201095159522

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sherief Abd-Elsalam

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

eldemerdash

Identifier Type: -

Identifier Source: org_study_id